Eun Seok Gil

This inventor holds 19 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Peptide Technology. Top assignees: 3-D Matrix, Ltd., Children's Medical Center Corporation, Tufts University. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eun Seok Gil. Retrieved from https://idiyas.com/inventor/eun-seok-gil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 23)

% Patents Active = 94.7

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 20)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 37(Granted Patents)

Location History:

Lexington, MA (US) (2021)
Acton, MA (US) (2019 - 2024)

Company Filing History:

Children's Medical Center Corporation

Vicus Therapeutics, LLC

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Self-Assembling Peptides

Biological Tissue Adhesion

Peptide Nanostructures

Drug Delivery

Sterilization Techniques

Tissue Regeneration

Wound Healing

Irradiation Methods

Multi-Layer Biomaterials

Combination Compositions

Anti-Adhesion

Autoassembling Peptides

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12642836 - IONIC SELF-ASSEMBLING PEPTIDES (2026-06-02),

2. 12377196 - Preventing biological tissue adhesion (2025-08-05),

3. 12239744 - Surfactant peptide nanostructures and uses thereof in drug delivery (2025-03-04),

4. 12115264 - Sterilization and filtration of peptide compositions (2024-10-15),

5. 12083243 - Sterilization of self-assembling peptides by irradiation (2024-09-10),

6. 11738114 - Sterilization of self-assembling peptides by irradiation (2023-08-29),

7. 11738113 - Sterilization of self-assembling peptides by irradiation (2023-08-29),

8. 11617778 - Ionic self-assembling peptides (2023-04-04),

9. 11534528 - Sterilization of self-assembling peptides by irradiation (2022-12-27),

10. 11497833 - Self-assembling peptides comprising non-Ionic polar amino acids (2022-11-15),

11. 11324703 - Surfactant peptide nanostructures and uses thereof in drug delivery (2022-05-10),

12. 11090398 - Sterilization and filtration of peptide compositions (2021-08-17),

13. 10961274 - Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion (2021-03-30),

14. 10912862 - Multi-layer biomaterial for tissue regeneration and wound healing (2021-02-09),

15. 10814038 - Combination compositions (2020-10-27),

Title: **Eun Seok Gil: Innovator in Biological Tissue Adhesion and Drug Delivery**

Introduction

Eun Seok Gil, based in Acton, MA, has made significant contributions to the fields of biomedical engineering and drug delivery, securing an impressive total of 18 patents throughout his career. His innovative approaches address critical challenges in biological tissue adhesion and drug delivery systems, showcasing his commitment to advancing medical technology.

Latest Patents

Among Eun Seok Gil's latest patents is a groundbreaking method for **preventing biological tissue adhesion**. This patent describes techniques and materials that effectively mitigate tissue adhesion by administering a self-assembling peptide solution. This solution, composed of peptides ranging from 7 to 32 amino acids, forms a hydrogel under physiological conditions, offering promising applications in surgical procedures.

Another notable invention involves the development of **surfactant peptide nanostructures** designed for drug delivery. These nanostructures consist of peptides characterized by repeating hydrophobic amino acids, facilitating their use in delivering therapeutic agents, including drugs and siRNA. This innovation holds great potential for enhancing the effectiveness of treatments in various medical applications.

Career Highlights

Eun Seok Gil has worked with notable organizations, including 3D Matrix, Ltd. and Children's Medical Center Corporation, contributing to the development of innovative biomedical solutions. His involvement in these companies has allowed him to translate his research into real-world applications, benefiting patients and healthcare providers alike.

Collaborations

Throughout his career, Eun has collaborated with esteemed professionals such as Karl Patrick Gilbert and Elton Aleksi. These partnerships have fostered a collaborative environment for innovation, allowing for the exchange of ideas and expertise that drive advancements in their respective fields.

Conclusion

Eun Seok Gil stands out as a distinguished inventor whose work in biological tissue adhesion and drug delivery continues to influence the medical field. His 18 patents reflect his dedication to improving patient outcomes through innovative technologies. With a strong foundation built on research and collaboration, Eun Seok Gil’s contributions are poised to make a lasting impact on the future of biomedical engineering.

Profile summary based on public USPTO records.